Senzime AB
Update in progressSEZI.ST (Stockholm)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Senzime AB (publ) is a medical device company that develops, manufactures, and markets algorithm-powered patient monitoring systems to improve safety during and after surgery in Europe and the United States. Its products include TetraGraph, a quantitative neuromuscular monitor; ExSpiron, a non-invasive tissue impedance monitor; and CliniSenz Analyzer and OnZurf Probe. It has licensing partnerships with Masimo, Fukuda Denshi, and CoreSpiron, and is based in Uppsala, Sweden.
Company score
- Sentiment
- 0.17
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.06
- Governance
- 0.05
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.03
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.10
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!